47522 Federal Register / Vol. 86, No. 162 / Wednesday, August 25, 2021 / Notices 

comments on or objections to the 

issuance of the proposed registration on 

or before September 24, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 24, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 20, 2021, 

Cedarburg Pharmaceuticals, 870 Badger 

Circle Drive, Grafton, Wisconsin 53024– 

9436, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric Acid .... 2010 I 

Marihuana Extract ..................... 7350 I 

Marihuana ................................. 7360 I 

The company plans to import Sodium 

Oxybate (derivative of GammaHydroxybutyric Acid) to support 

Euticals Inc. post procurement quota 

grand. The cannabidiol from Marihuana 

and Marihuana Extracts is intended for 

analytical purposes with 

tetramethylpyrazine. No other activity 

for this drug code is authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–18233 Filed 8–24–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–890] 

Importer of Controlled Substances 

Application: Johnson Matthey Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Johnson Matthey Inc., has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 24, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 24, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on July 23, 2021, Johnson 

Matthey Inc., 2003 Nolte Drive, West 

Deptford, New Jersey 08066–1742, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Nabilone .......................... 7379 II 

The company plans to import 

Nabilone (7379) in order to accept the 

return of this controlled substance from 

a foreign customer who no longer has a 

demand for this substance. No other 

activity for this drug code is authorized 

for this registration. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–18238 Filed 8–24–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–860] 

Bulk Manufacturer of Controlled 

Substances Application: Absolute 

Standards, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Absolute Standards, Inc., has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before October 25, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 25, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on May 31, 2021, Absolute 

Standards, Inc., 44 Rossotto Drive, 

Hamden, Connecticut 06514–1335, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance: 

Controlled substance Drug 

code Schedule 

Pentobarbital ................... 2270 II 

The company plans to bulk 

manufacture the listed controlled 

substances for internal use and for sale 

to its customers. No other activities for 

these drug codes are authorized for this 

registration. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–18230 Filed 8–24–21; 8:45 am] 

BILLING CODE P 


khammond on DSKJM1Z7X2PROD with NOTICES

I I 

I I 

I I